Myriad Genetics, Inc. (MYGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Myriad Genetics, Inc. (MYGN)

MYGN 7.450

+8.0%

2:22 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Al's Fun who wrote (40)	9/10/1999 1:21:00 AM
From: Larry Liebman	Read Replies (1) of 2355

FWIW, I added some more MYGN at $14. Looking at genomic valuations, MYGN has a cap of approx. $132 million, book of $5+, float of <7 million sh. Conference call suggested MYGN is expecting further pharma collaborations. Novartis stated that MYGN was selected "as the preferred partner for projects of this scale". I believe that analyst recommendations will follow.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next